The ubiquitination degradation of KLF15 mediated by WSB2 promotes lipogenesis and progression of hepatocellular carcinoma via inhibiting PDLIM2 expression
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.16812 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Jing Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The Third Affiliated Hospital of Suzhou University, The First People's Hospital of Changzhou, Cha…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Lipogenesis, LIM Domain Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Changzhou High Level Medical Talents Training Project, Major Program of Science and Technology Project of Changzhou Health Commission, Fifth Phase of the Provincial "333 Project" Culture.
Abstract (Originalsprache)
Background and Aim Krüppel‐like factors15 (KLF15) is a cancer suppressor in many cancers. However, its precise function in the development of hepatocellular carcinoma (HCC) remains unclear. Lipogenesis is necessary for the development of HCC. This research aims to investigate the role of KLF15 in the regulation of hepatic lipid production and HCC progression.
Methods
The binding relationships among genes were confirmed by ChIP, dual luciferase assays, and Co‐IP. Lipogenesis was examined by oil red O staining. Triglyceride and cholesterol levels were measured through commercial kits. The effect of treatment on HCC cell viability, proliferation, migration, and invasion were assessed using CCK‐8, clone formation, or transwell assays. A subcutaneous tumorigenic model was utilized to explore the effects of PDLIM2 in HCC in vivo.
Results
KLF15 were downregulated in human HCC tissues. KLF15 overexpression reduced lipid droplet production, suppressed the expression of genes associated with lipogenesis, and promoted cell proliferation, migration, and invasion. KLF15 suppressed the NF‐κB pathway through transcriptional activation of PDLIM2. PDLIM2 knockdown attenuated the effect of KLF15 overexpression on HCC. WSB2 degraded KLF15 through ubiquitination to promote HCC lipogenesis and development.
Conclusion
The ubiquitination degradation of KLF15 was mediated by WSB2, which led to transcriptional repression of PDLIM2 and further activation of the NF‐κB pathway, ultimately promoting HCC lipogenesis and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The Third Affiliated Hospital of Suzhou University, The First People's Hospital of Changzhou, Changzhou, China.
- Department of Gastroenterology, The Third Affiliated Hospital of Suzhou University, The First People's Hospital of Changzhou, Changzhou, China.
- Department of Anesthesiology, The Third Affiliated Hospital of Suzhou University, The First People's Hospital of Changzhou, Changzhou, China.
ORCID-Profile: Cao Gao
Förderung
- Changzhou High Level Medical Talents Training Project
- Major Program of Science and Technology Project of Changzhou Health Commission
- Fifth Phase of the Provincial "333 Project" Culture
Zitieren
APA
Chen, J., Chen, X., Cai, H., Yang, Y., Zhu, Q., Sun, D., & Gao, C. (2025). The ubiquitination degradation of KLF15 mediated by WSB2 promotes lipogenesis and progression of hepatocellular carcinoma via inhibiting PDLIM2 expression. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16812
Vancouver
Chen J, Chen X, Cai H, Yang Y, Zhu Q, Sun D, et al. The ubiquitination degradation of KLF15 mediated by WSB2 promotes lipogenesis and progression of hepatocellular carcinoma via inhibiting PDLIM2 expression. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16812
BibTeX
@article{Chen2025,
author = {Chen, Jing and Chen, Xuemin and Cai, Huihua and Yang, Yong and Zhu, Qinqin and Sun, Donglin and Gao, Cao},
title = {The ubiquitination degradation of KLF15 mediated by WSB2 promotes lipogenesis and progression of hepatocellular carcinoma via inhibiting PDLIM2 expression},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.16812}
}
EUVIMED